San Diego, CA -- (SBWire) -- 06/18/2013 --An investigation on behalf of current long-term stockholders of shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was announced concerning whether certain Infinity Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.
Investors who are current long-term stockholder of shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Infinity Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders by, among other things, failing to implement adequate internal controls.
Shares of Infinity Pharmaceuticals Inc. grew from $22.525 in early Dec. 2012 to as high as over $50 per share in early April 2013.
Then on May 7, 2013, Infinity Pharmaceuticals Inc. reported its Frist Quarter 2013 Financial Results.
Shares of Infinity Pharmaceuticals Inc. declined to as low as $23.38 per share on May 17, 2013.
On June 17, 2013, shares of Infinity Pharmaceuticals Inc closed at $17.17 per share.
Those who purchased shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI), have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Jacob Rosenfeld
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Investor Alert: Investigation over Potential Wrongdoing
An investigation for current long-term investors in shares of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) over potential wrongdoing by certain officers and directors was announced and NASDAQ:INFI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com